This list is an analysis based on recent market events. It's not an investment recommendation.
Based in Copenhagen, Denmark, 2cureX AB (publ) is a European medtech firm established in 2006. The company's core offering is IndiTreat, an in-vitro diagnostic test designed to forecast how cancer patients will respond to or resist various drug treatments, thereby guiding clinicians in selecting the most effective therapy. Additionally, 2cureX is actively advancing IndiTreat through clinical programs targeting a range of cancers, including breast, colorectal, ovarian, and pancreatic types.
FAQs
What is 2cureX AB stock price today?▼
The current price of 2QE.MU is €0.05 EUR — it has decreased by -1.2% in the past 24 hours. Watch 2cureX AB stock price performance more closely on the chart.
What is 2cureX AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange 2cureX AB stocks are traded under the ticker 2QE.MU.
Is 2cureX AB stock price growing?▼
2QE.MU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year 2cureX AB has showed a -53.18% decrease.
What is 2cureX AB market cap?▼
Today 2cureX AB has the market capitalization of 1.24M
What is 2cureX AB revenue for the last year?▼
2cureX AB revenue for the last year amounts to -63.56 EUR.
What is 2cureX AB net income for the last year?▼
2QE.MU net income for the last year is -236,170.21 EUR.
How many employees does 2cureX AB have?▼
As of November 2, 2026, the company has 14 employees.
In which sector is 2cureX AB located?▼
2cureX AB operates in the Health & Wellness sector.
When did 2cureX AB complete a stock split?▼
The last stock split for 2cureX AB was on July 16, 2020 with a ratio of 11:10.
Where is 2cureX AB headquartered?▼
2cureX AB is headquartered in Landskrona, Denmark.